Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy responseYan Mei, Guangshuai Jia, Xiumei Wang et al.|Nature Cancer|2023Cited by 219
One-step generation of different immunodeficient mice with multiple gene modifications by CRISPR/Cas9 mediated genome engineeringJiankui Zhou, Xingxu Huang, Bian Hu et al.|The International Journal of Biochemistry & Cell Biology|2013Cited by 122
NCoR1 restrains thymic negative selection by repressing Bim expression to spare thymocytes undergoing positive selectionJian‐Rong Wang, Qibin Leng|Nature Communications|2017Cited by 26
Macrophage NCOR1 Deficiency Ameliorates Myocardial Infarction and Neointimal Hyperplasia in MiceLin‐Juan Du, Sheng‐Zhong Duan, Jianyong Sun et al.|Journal of the American Heart Association|2020Cited by 25